Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Aronson

Showing results (351-360 of 634) with videos related to

Pageof 64
Sort By:
BMJ (Clinical Research Ed.)|September 17, 2010
Length of treatment. Three questions for prescribersJeffrey K Aronson, Robin E Ferner
BMJ (Clinical Research Ed.)|April 10, 2020
Chloroquine and hydroxychloroquine in covid-19Robin E Ferner, Jeffrey K Aronson
British Journal of Clinical Pharmacology|June 1, 1995
Prolonged half-life of verapamil in a case of overdose: implications for therapyC D Buckley, J K Aronson
BMJ (Clinical Research Ed.)|November 21, 1992
ABC of monitoring drug therapy. LithiumJ K Aronson, D J Reynolds
Lancet (London, England)|June 27, 1981
Interaction of digoxin with quinineJ K Aronson, J G Carver
Drug Safety|September 27, 2005
Clarification of terminology in drug safetyJeffrey K Aronson, Robin E Ferner
British Journal of Clinical Pharmacology|December 21, 2004
National differences in publishing papers on adverse drug reactionsR E Ferner, J K Aronson
BMJ (Clinical Research Ed.)|July 15, 2006
Communicating information about drug safetyR E Ferner, J K Aronson
Drug Safety|October 26, 2006
Clarification of terminology in medication errors: definitions and classificationRobin E Ferner, Jeffrey K Aronson
Lancet (London, England)|April 24, 2007
Give a drug a good nameDinesh K Mehta, Jeffrey K Aronson
Pageof 64

Showing results (351-360 of 634) with videos related to

Sort By:
Pageof 64
BMJ (Clinical Research Ed.)|September 17, 2010
Length of treatment. Three questions for prescribersJeffrey K Aronson, Robin E Ferner
BMJ (Clinical Research Ed.)|April 10, 2020
Chloroquine and hydroxychloroquine in covid-19Robin E Ferner, Jeffrey K Aronson
British Journal of Clinical Pharmacology|June 1, 1995
Prolonged half-life of verapamil in a case of overdose: implications for therapyC D Buckley, J K Aronson
BMJ (Clinical Research Ed.)|November 21, 1992
ABC of monitoring drug therapy. LithiumJ K Aronson, D J Reynolds
Lancet (London, England)|June 27, 1981
Interaction of digoxin with quinineJ K Aronson, J G Carver
Drug Safety|September 27, 2005
Clarification of terminology in drug safetyJeffrey K Aronson, Robin E Ferner
British Journal of Clinical Pharmacology|December 21, 2004
National differences in publishing papers on adverse drug reactionsR E Ferner, J K Aronson
BMJ (Clinical Research Ed.)|July 15, 2006
Communicating information about drug safetyR E Ferner, J K Aronson
Drug Safety|October 26, 2006
Clarification of terminology in medication errors: definitions and classificationRobin E Ferner, Jeffrey K Aronson
Lancet (London, England)|April 24, 2007
Give a drug a good nameDinesh K Mehta, Jeffrey K Aronson
Pageof 64